Evaluation of Protein-Ligand binding interactions of alkaline phosphatase inhibitors by Quantum-Mechanical methods
Abstract
Quantum-mechanical (QM) methods were applied to compute the relative binding energies of a set of structurally similar alkaline phosphatase (AP) inhibitors, using human placental AP (PLAP) as a model AP. The theoretical binding affinities were compared with their corresponding experimental inhibitory potencies. The calculated interaction energies reproduced the experimental activity order, showing linear correlations between QM relative binding energies and experimental pIC50 values with coefficients of determination R2 = 0.86-0.97. Examination of the binding interactions for the test inhibitors revealed that the AP inhibitory activity is determined by the catechol group and the benzimidazole/imidazole moieties of the ligands. The studied compounds formed protein-ligand complexes inside the active site of PLAP, suggesting they are competitive inhibitors. The present theoretical results are expected to be useful in developing new potent AP inhibitors. The employed computational approach for estimating QM protein - ligand interaction energies is proposed as a suitable drug design tool for predicting reliable QM relative binding affinities of structurally related compounds.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.